Bibliography
- GRUNDY SM, BREWER HBJ, CLEEMAN JI et al.: Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation (2004) 109:433–438.
- JAMES WPT: Appropriate Asian body mass indices? Obesity Rev (2002) 3:139.
- WILLIAMSON DF, PAMUK E, THUN M et al.: Prospective study of intentional weight loss and mortality in never-smoking overweight US white women aged 40 — 64 years. Am. .1. Epidemiol (1995) 141:1128–1141.
- SJOSTROM CD, LISSNER L, WEDEL H, SJOSTROM L: Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study. Obes. Res. (1999) 7:477–484.
- REAVEN G, SEGAL K, HAUPTMAN J,BOLDRIN M, LUCAS C: Effect of orlistat-assisted weight loss in decreasing coronary heart disease risk in patients with syndrome X. Am. J. Cardiol. (2001) 87:827–831.
- MOLLER DM, KAUFMAN KD: Metabolic syndrome — a clinical and molecular perspective. Ann. Rev Med. (2004) (In Press).
- OLIVER WRJ, SHENK JL, SNAITH MR et al.: A selective perwdsome proliferator-activated receptor delta agonist promotes reverse cholesterol transport. Proc. Natl. Acad. Sci. USA (2001) 98:5306–5311.
- PRATLEY R, GALBREATH E. Twelve-week monotherapy with the DPP-4 inhibitor LAF-237 improves glycemic control in patients with Type 2 diabetes. American Diabetes Association 64th Annual Scientific Sessions. Florida USA (2004) 355-0R.
- HERMAN GA, ZHAO P-L, DIETRICH B et al: The DP-IV inhibitor MK-0431 enhances active GLP-1 and reduces glucose following an OGTT in Type 2 diabetics. American Diabetes Association 64th Annual cientific Sessions. Florida, USA (2004) 353-0R.
- BREWER HB Jr: High density lipoproteins: a new potential therapeutic target for the prevention of cardiovascular disease. Artheriosclic TM-0mb. Vasc. Biol. (2004) 24:387–391.
- GANTZ I, FONG TM: The melanocortin systems. Arn. J. Physic] (2003). 284:E468–E474.